| 1 | 100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 2 | 100 mg ELX /50 mg TEZ /75 mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 3 | 100 mg ELX/50 mg TEZ /75 mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 4 | 100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination | - | - | - | - | [1] 299 299 💬
|
| 5 | 100 mg VX-445 /50 mg TEZ/75 mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 6 | 100 mg VX-445/50 mg TEZ /75 mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 7 | 100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 8 | 100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 9 | 100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 10 | 100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 11 | 100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 12 | 100-mg VX-445 /50-mg TEZ/75-mg | - | - | - | - | [1] 299 299 💬
|
| 13 | 100-mg VX-445/50-mg TEZ/75-mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 14 | 100g ELX / 50mg TEZ / 75mg IVA | - | - | - | - | [1] 299 299 💬
|
| 15 | 100mg ELX/50mg TEZ /75mg IVA | - | - | - | - | [1] 299 299 💬
|
| 16 | 100mg VX-445/50mg TEZ /75mg IVA FDC | - | - | - | - | [1] 299 299 💬
|
| 17 | 56/104/75-C | - | - | - | - | [1] 50 50 💬
|
| 18 | 75 | - | - | - | - | [1] 6 6 💬
|
| 19 | 75 mg Ontamalimab | [1] Ontamalimab Ontamalimab | - | - | - | [2] 96 96, 97 💬
|
| 20 | 75-mg IVACAFTOR | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 21 | 750 mg metformin and 7.5 g L-citrulline daily p.o. | [2] Citrulline Citrulline, Metformin (Metformin ER 750 mg) | [1] Metformin
Metformin
💬
| [2] PRKAA1 PRKAA1, PRKAA2 💬
| [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 💬
|
| 22 | 750mg mesalazine pellets | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 23 | 75mg CXA-10 | [1] CXA-10 CXA-10 | - | - | - | [1] 86 86 💬
|
| 24 | 75mg SHP647 (PF-00547659) | - | - | - | - | [1] 97 97 💬
|
| 25 | AIN457, 75 mg | - | - | - | - | [1] 271 271 💬
|
| 26 | Atacicept 75 mg | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [3] 13 13, 49, 66 💬
|
| 27 | Atacicept 75 milligram (mg) | [1] Atacicept Atacicept | [1] Atacicept
Atacicept
💬
| [2] TNFSF13 TNFSF13, TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 28 | AZLI 75 mg three times a day (TID) | - | - | - | - | [1] 299 299 💬
|
| 29 | AZLI 75 mg three times daily (TID) | - | - | - | - | [1] 299 299 💬
|
| 30 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | [1] 299 299 💬
|
| 31 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | [1] 299 299 💬
|
| 32 | Betaloc ZOK 25, 23,75 mg | - | - | - | - | [1] 113 113 💬
|
| 33 | BMS-986004 75 mg IV | - | - | - | - | [1] 63 63 💬
|
| 34 | Catapresan 75 | - | - | - | - | [1] 78 78 💬
|
| 35 | Catapresan 75, Tabletten | - | - | - | - | [1] 65 65 💬
|
| 36 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | [1] Aztreonam Aztreonam | [1] Aztreonam
Aztreonam
💬
| - | - | [1] 299 299 💬
|
| 37 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | [1] Aztreonam Aztreonam | [1] Aztreonam
Aztreonam
💬
| - | - | [1] 299 299 💬
|
| 38 | Certican 0,75mg | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬
| [1] MTOR MTOR 💬
| [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 💬
|
| 39 | Certican 0,75mg Tabletten | [1] Everolimus Everolimus | [1] Everolimus
Everolimus
💬
| [1] MTOR MTOR 💬
| [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 228 228 💬
|
| 40 | Cohort 2 0.75g | - | - | - | - | [1] 240 240 💬
|
| 41 | Colistimethate 75 mg inhaled two times daily | [1] Colistimethate Colistimethate | - | - | - | [1] 299 299 💬
|
| 42 | Continuous oxygen (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 90 90 💬
|
| 43 | CVL-751 | - | - | - | - | [1] 6 6 💬
|
| 44 | Depot leuprolide acetate 3.75 mg | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 51 51 💬
|
| 45 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | [1] Dulaglutide Dulaglutide | [1] Dulaglutide
Dulaglutide
💬
| [1] GLP1R GLP1R 💬
| [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 46 | Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml | - | - | - | - | [1] 96 96 💬
|
| 47 | Efexor XL 75 mg | - | - | - | - | [1] 46 46 💬
|
| 48 | Efexor XL 75 mg (venlafaxine) | [1] Venlafaxine Venlafaxine | [1] Venlafaxine
Venlafaxine
💬
| [2] SLC6A2 SLC6A2, SLC6A4 💬
| [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 46 46 💬
|
| 49 | Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening | [3] Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | [3] Ivacaftor
Ivacaftor
,
Tezacaftor
,
Elexacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 50 | Helium / oxygen mixed gas inhalation therapy (OXYGEN/HELIUM 25/75) | [2] Helium Helium, Oxygen (Oxygen/Helium 25/75) | [2] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75),
Helium
💬
| - | - | [1] 330 330 💬
|
| 51 | IncobotulinumtoxinA (75 Units) | [1] Botulinum toxin type A Botulinum toxin type A | [1] Botulinum toxin type A
Botulinum toxin type A
💬
| [1] SNAP25 SNAP25 💬
| [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 6 6 💬
|
| 52 | Inhaled nitric oxide 75 mcg/kg IBW/hr | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [2] 85 85, 86 💬
|
| 53 | INM-755 | - | - | - | - | [1] 36 36 💬
|
| 54 | INM-755 (cannabinol) cream | [1] Cannabinol Cannabinol | - | - | - | [1] 36 36 💬
|
| 55 | Irbesartan tablets (NDA 020 757) | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
| 56 | Ivacaftor 25 mg/75 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 57 | Ivacaftor 75 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 58 | Ivacaftor 75 mg/150 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 59 | IVACAFTOR 75mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 60 | Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 85 85 💬
|
| 61 | Jaktinib Dihydrochloride Monohydrate 75mg BID and Mimic tablets of jakitinib hydrochloride 50mg BID and Acetylcysteine Effervescent Tablets | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [1] 85 85 💬
|
| 62 | JNJ-54781532 75 mg once daily | - | - | - | - | [1] 97 97 💬
|
| 63 | JNJ-54781532 75 mg twice daily | - | - | - | - | [1] 97 97 💬
|
| 64 | Leuprorelin Acetate 3.75mg Injection | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 76 76 💬
|
| 65 | Levodopa 75 mg A CAP | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 66 | LIQ861 75 µg | - | - | - | - | [1] 86 86 💬
|
| 67 | Luphere depot 3.75mg(Leuprolide acetate 3.75mg) | [2] Acetate Acetate, Leuprolide | - | - | - | [1] 76 76 💬
|
| 68 | M2951 75 mg QD | - | - | - | - | [1] 46 46 💬
|
| 69 | Macitentan 75 mg | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 70 | Medical Air vs Oxygen (OXYGEN/HELIUM 25/75) | [2] Medical air Medical air, Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 193 193 💬
|
| 71 | Medical Grade Oxygen (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 299 299 💬
|
| 72 | MetoHEXAL® Succ ® 23,75 mg Retardtabletten | - | - | - | - | [1] 113 113 💬
|
| 73 | Nitric Oxide plus Oxygen (OXYGEN/HELIUM 25/75) | [2] Nitric Oxide Nitric Oxide, Oxygen (Oxygen/Helium 25/75) | [2] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75),
Nitric oxide
💬
| - | - | [1] 86 86 💬
|
| 74 | Oral Glucose Tolerance test (75g 2-hour) | [1] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 💬
|
| 75 | Over-encapsulated 75 mg Irbesartan Tablets | [1] Irbesartan Irbesartan | [1] Irbesartan
Irbesartan
💬
| [1] AGTR1 AGTR1 💬
| [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 76 | Oxygen (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [13] 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬
|
| 77 | Oxygen 40 % (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 85 85 💬
|
| 78 | Oxygen supplementation (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 86 86 💬
|
| 79 | Oxygen, liquid (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [2] 86 86, 88 💬
|
| 80 | Oxygen-15 Water (OXYGEN/HELIUM 25/75) | [2] Oxygen Oxygen (Oxygen/Helium 25/75), Water (GFA First Aid 75 Person Metal Case) | [2] Water
Water
,
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 6 6 💬
|
| 81 | P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), | [2] Pramipexole Pramipexole, Rasagiline | [3] Pramipexole
Pramipexole
,
Rasagiline
,
Rasagiline tartrate
💬
| [4] DRD2 DRD2, DRD3, DRD4, MAOB 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 82 | P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), | [2] Pramipexole Pramipexole, Rasagiline | [3] Pramipexole
Pramipexole
,
Rasagiline
,
Rasagiline tartrate
💬
| [4] DRD2 DRD2, DRD3, DRD4, MAOB 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 83 | P38 Inhibitor (4) 75mg | - | - | - | - | [1] 46 46 💬
|
| 84 | Perfluorinated gas/oxygen mixture (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 299 299 💬
|
| 85 | Pregabalin 75mg | [1] Pregabalin Pregabalin (Pregabalin-75) | [1] Pregabalin
Pregabalin
💬
| [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬
| [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [1] 70 70 💬
|
| 86 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | [1] Ranolazine Ranolazine | [1] Ranolazine
Ranolazine
💬
| - | - | [1] 58 58 💬
|
| 87 | RANEXA*60CPR 750MG R.P. | [1] Ranolazine Ranolazine | [1] Ranolazine
Ranolazine
💬
| - | - | [1] 58 58 💬
|
| 88 | Ranolazine 750 mg PR tablets | [1] Ranolazine Ranolazine | [1] Ranolazine
Ranolazine
💬
| - | - | [1] 58 58 💬
|
| 89 | Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die | [1] Ranolazine Ranolazine | [1] Ranolazine
Ranolazine
💬
| - | - | [1] 58 58 💬
|
| 90 | Revolade 75 mg | [1] Eltrombopag Eltrombopag | - | - | - | [1] 60 60 💬
|
| 91 | RhuDex 25 mg (31.75 mg RhuDex choline salt) granules | [1] Choline Choline (Magnum-75 Vitamin and Mineral Supplement) | [1] Choline
Choline
💬
| - | - | [1] 93 93 💬
|
| 92 | RO 487-7533 | - | - | - | - | [1] 46 46 💬
|
| 93 | Ro 487-7533/F01 | - | - | - | - | [3] 46 46, 107, 271 💬
|
| 94 | Ro 487-7533/F10 | - | - | - | - | [2] 46 46, 107 💬
|
| 95 | Ro 487-7533/F10-02 | - | - | - | - | [1] 46 46 💬
|
| 96 | Ro 487-7533/F10-04 | - | - | - | - | [4] 41 41, 46, 51, 107 💬
|
| 97 | Ro 491-7523/F18 | - | - | - | - | [1] 206 206 💬
|
| 98 | Ro 491-7523/F19 | - | - | - | - | [1] 206 206 💬
|
| 99 | Ro487-7533 | - | - | - | - | [1] 46 46 💬
|
| 100 | RO487-7533/F01-F05 | - | - | - | - | [1] 46 46 💬
|
| 101 | RO487-7533/F10-04 | - | - | - | - | [2] 46 46, 51 💬
|
| 102 | Secukinumab (75 mg) | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 103 | Secukinumab 75 mg/0.5 ml Solution for injection | [1] Secukinumab Secukinumab | [1] Secukinumab
Secukinumab
💬
| [1] IL17A IL17A 💬
| [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 💬
|
| 104 | Standard analgesia use [Oxygen] (OXYGEN/HELIUM 25/75) | [1] Oxygen Oxygen (Oxygen/Helium 25/75) | [1] Oxygen
Oxygen
(OXYGEN/HELIUM 25/75) 💬
| - | - | [1] 70 70 💬
|
| 105 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | [1] 97 97 💬
|
| 106 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 💬
|
| 107 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 💬
|
| 108 | TAK-755 | - | - | - | - | [1] 64 64 💬
|
| 109 | TAK-755 or BAX930 or SHP655 | - | - | - | - | [1] 64 64 💬
|
| 110 | TAK-755 orBAX930 or SHP655 | - | - | - | - | [1] 64 64 💬
|
| 111 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere | [1] Dulaglutide Dulaglutide | [1] Dulaglutide
Dulaglutide
💬
| [1] GLP1R GLP1R 💬
| [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 112 | Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. | [1] Dulaglutide Dulaglutide | [1] Dulaglutide
Dulaglutide
💬
| [1] GLP1R GLP1R 💬
| [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 113 | TSO 7500 | - | - | - | - | [1] 96 96 💬
|
| 114 | Vamorolone 0.75 mg/day/day | [1] Vamorolone Vamorolone | [1] Vamorolone
Vamorolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 💬
|
| 115 | Vamorolone 0.75 mg/kg/day | [1] Vamorolone Vamorolone | [1] Vamorolone
Vamorolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 113 113 💬
|
| 116 | Veltuzumab solution 75mg/ml | [1] Veltuzumab Veltuzumab | [1] Veltuzumab
Veltuzumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 💬
|
| 117 | VX-661/ivacaftor 50 mg/ 75 mg | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|